0001551163-24-000026.txt : 20240515 0001551163-24-000026.hdr.sgml : 20240515 20240515133734 ACCESSION NUMBER: 0001551163-24-000026 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 EFFECTIVENESS DATE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOETHICS LTD CENTRAL INDEX KEY: 0000894560 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 870485312 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 033-55254-41 FILM NUMBER: 24949096 BUSINESS ADDRESS: STREET 1: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 BUSINESS PHONE: (801) 399-3632 MAIL ADDRESS: STREET 1: 1661 LAKEVIEW CIRCLE CITY: OGDEN STATE: UT ZIP: 84403 NT 10-Q 1 bioethics20240331b25.htm SEC FILE NUMBER:  000 30239

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

 

FORM 12b-25 

 

NOTIFICATION OF LATE FILING 

 

(Check One):  [ ] Form 10-K [  ] Form 20-F [ ] Form 11-K  [X] Form 10-Q [ ] Form 10-D 

[ ] Form N-SAR  [  ] Form N-CSR 

 

For Period Ended: March 31, 2024

[  ] Transition Report on Form 10-K

[  ] Transition Report on Form 20-F

[  ] Transition Report on Form 11-K

[  ] Transition Report on Form 10-Q

[  ] Transition Report on Form N-SAR

For the Transition Period Ended:   

 

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

 

 

PART I - REGISTRANT INFORMATION

 

BIOETHICS, LTD.  

Full Name of Registrant

 

 

Former Name if Applicable

 

1661 Lakeview Circle,  

Address of Principal Executive Office (Street and Number)

 

Ogden, UT 84403 

City, State and Zip Code

 

PART II - RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate)

 

 

 

 

(a)

 

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

 

[x]

 

(b)

 

The subject annual report, semi-annual report; transition report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

 

(c)

 

The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

PART III - NARRATIVE

 

State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR or the transition report or portion thereof, could not be filed within the prescribed time period.  (Attach Extra Sheets If Needed)

The Registrant is unable to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 by the prescribed due date because the review of the Registrant’s financial statements to be included in the Form 10-Q has not yet been completed.  The Registrant anticipates that the review will be completed in time for the report to be filed on or before the fifth calendar day following the prescribed due date.

 

PART IV - OTHER INFORMATION

 

(1)Name and telephone number of person to contact in regard to this notification 

 

  Mark A. Scharmann         (801)          399-3632       

    (Name)     (Area Code)(Telephone Number) 

 

(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months (or for such shorter) period that the registrant was required to file such reports) been filed?  If answer is no, identify report(s). [X] Yes   [ ] No 

 

(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? [  ] Yes   [X] No 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

 

 

BIOETHICS, LTD. has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date May 15, 2024By:/s/ Mark A. Scharmann 

Mark A. Scharmann, Chief Executive Officer